stock decline

ADMA Biologics faces securities fraud investigation after short report alleges $20% growth claims masked 3% actual revenue decline, triggering 30% stock collapse.

PayPal ($PYPL) faces class action lawsuit alleging securities fraud tied to February 2026 CEO departure and disappointing earnings, with stock plunging 20.3%.

Class action lawsuit filed against $SLNO for allegedly concealing safety concerns and patient death related to experimental drug DCCR, causing significant shareholder losses.

PRFX stock tumbled Tuesday amid broader market weakness as investors remain skeptical the company's LayerBio and DeepSolar acquisitions can generate sustainable revenue.

Profusa shares crashed 40% Tuesday after announcing $30M all-equity deal to acquire BioInsights' multi-omics diagnostics platform, expanding into molecular cancer detection.

PMGC Holdings shares dropped 9.37% after announcing a drone technology option agreement via NorthStrive Defense Tech subsidiary, amid concerns about execution and 98.88% year-long decline.

Dutch Bros stock down 24% in three months amid consumer spending concerns, but the company delivered 29% revenue growth and record unit economics, trading at a 0.87 PEG ratio.

NuScale stock fell 15.6% in March after disappointing Q4 earnings, prompting analyst downgrades. Revenue declined 15% to $31.5M, but 2030 commercialization timeline remains on track.

Rosen Law Firm investigates $CRMT over alleged misleading disclosures. Stock fell 18.2% after company reported Q1 loss of 69 cents per share versus 15 cents prior year.

Apollo Global Management faces class action lawsuit alleging senior leadership concealed communications with Jeffrey Epstein. Stock fell $5.99/share after February 2026 disclosures.

Ultragenyx faces class action lawsuit over misleading statements on setrusumab efficacy. Stock crashed 42% after Phase III trials failed. Lead plaintiff deadline: April 6, 2026.

Oracle stock down 24% in 2026 amid AI spending concerns, but $553B backlog and robust cloud growth suggest upside potential for long-term investors.

Enphase Energy faces class action lawsuit alleging false statements about inventory management. Stock fell 15% after October disclosure. Investor deadline: April 20, 2026.

DNOW Inc. stock plummeted 19.1% following weak Q4 2025 earnings. Rosen Law Firm investigating potential securities claims for affected investors.

Rosen Law Firm investigates DNOW Inc. after Q4 2025 miss triggers 19.1% stock plunge, alleging materially misleading business disclosures to investors.

uniQure faces securities investigation after FDA publicly disputed the company's claims about regulatory guidance for gene therapy candidate AMT-130, with April 2026 deadline for investor class action.

PayPal faces class action lawsuit after Q4 2025 earnings miss and withdrawal of 2027 targets triggered over 20% stock decline.

Planet Fitness shares plunge 32% amid slowing growth, though the company added 181 clubs and raised prices 50%. Valuation remains stretched at 28x earnings.

Law firm Kirby McInerney LLP files securities class action against Driven Brands Holdings Inc. ($DRVN) following material financial restatement citing unreconciled cash and overstated revenue.

Vital Farms missed 2025 guidance citing ERP system disruptions, triggering 11% stock decline and class action lawsuit.